Literature DB >> 28921171

High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.

D H Lee1, B K Lee2, S M Noh3, Y S Cho1.   

Abstract

PURPOSE: There is a lack of association between coagulation biomarkers and long-term mortality in severe trauma. We aimed to investigate the association between coagulation biomarkers on admission and outcome of late stage of trauma.
METHODS: This retrospective observational study included patients admitted with severe trauma between 2012 and 2015. We used the area under the receiver operating characteristic curve (AUROC) of coagulation biomarkers to determine 28-day mortality. Head Abbreviated Injury Scale scores greater than 3 were defined as traumatic brain injury (TBI). The primary outcome was 28-day mortality and the secondary outcome was massive transfusion.
RESULTS: Of the 1266 patients included in the study, 28-day mortality rate was 19.7% (n = 249) and 7.9% (n = 100) of patients received massive transfusion. The AUROC of fibrin/fibrinogen degradation product (FDP) to fibrinogen ratio had a significantly higher prognostic performance than other markers. Multivariate analysis revealed that D-dimer level [odds ratio (OR) 1.033; 95% confidence interval (CI) 1.016-1.051] and FDP/fibrinogen ratio (OR 1.007; 95% CI 1.001-1.013) were independently associated with 28-day mortality. D-dimer (OR 1.028; 95% CI 1.003-1.055) and FDP/fibrinogen ratio (OR 1.035; 95% CI 1.012-1.058) were associated with 28-day mortality in the TBI group. In the non-TBI group, D-dimer was associated with 28-day mortality (OR 1.033; 95% CI 1.008-1.059), but the FDP/fibrinogen ratio was not. FDP/fibrinogen ratio, not D-dimer level, was an independent predictor for massive transfusion (OR 1.005; 95% CI 1.001-1.010).
CONCLUSIONS: High FDP/fibrinogen ratio on arrival is a predictor of 28-day mortality and the requirement for massive transfusion in severe trauma.

Entities:  

Keywords:  D-dimer; Fibrin/fibrinogen degradation products (FDP); Fibrinogen; Massive transfusion; Prognosis; Trauma

Mesh:

Substances:

Year:  2017        PMID: 28921171     DOI: 10.1007/s00068-017-0844-0

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  25 in total

Review 1.  Are fibrin-related markers useful for the diagnosis of thrombosis?

Authors:  Hideo Wada; Nobuo Sakuragawa
Journal:  Semin Thromb Hemost       Date:  2008-02       Impact factor: 4.180

2.  Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited.

Authors:  N Cosgriff; E E Moore; A Sauaia; M Kenny-Moynihan; J M Burch; B Galloway
Journal:  J Trauma       Date:  1997-05

Review 3.  Disseminated intravascular coagulation in trauma patients.

Authors:  S Gando
Journal:  Semin Thromb Hemost       Date:  2001-12       Impact factor: 4.180

4.  Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.

Authors:  Mineji Hayakawa; Atsushi Sawamura; Satoshi Gando; Nobuhiko Kubota; Shinji Uegaki; Hidekazu Shimojima; Masahiro Sugano; Masahiro Ieko
Journal:  Surgery       Date:  2010-07-23       Impact factor: 3.982

5.  Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest.

Authors:  S Gando; T Kameue; S Nanzaki; Y Nakanishi
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

Review 6.  The coagulopathy of trauma versus disseminated intravascular coagulation.

Authors:  John R Hess; Jeffrey H Lawson
Journal:  J Trauma       Date:  2006-06

7.  Early trauma induced coagulopathy (ETIC): prevalence across the injury spectrum.

Authors:  Jana B A MacLeod; Anne M Winkler; Cameron C McCoy; Christopher D Hillyer; Beth H Shaz
Journal:  Injury       Date:  2013-11-20       Impact factor: 2.586

8.  Relationship between tissue perfusion and coagulopathy in traumatic brain injury.

Authors:  Simone E Dekker; Anne Duvekot; Hielke-Martijn de Vries; Leo M G Geeraedts; Saskia M Peerdeman; Monique C de Waard; Christa Boer; Patrick Schober
Journal:  J Surg Res       Date:  2016-06-15       Impact factor: 2.192

9.  Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.

Authors:  S Gando; Y Nakanishi; I Tedo
Journal:  Crit Care Med       Date:  1995-11       Impact factor: 7.598

Review 10.  Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options.

Authors:  Marc Maegele
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

View more
  2 in total

1.  The Association Between D-dimer Levels and Long-Term Neurological Outcomes of Patients with Traumatic Brain Injury: An Analysis of a Nationwide Observational Neurotrauma Database in Japan.

Authors:  Gaku Fujiwara; Yohei Okada; Takehiko Sakakibara; Tarumi Yamaki; Naoya Hashimoto
Journal:  Neurocrit Care       Date:  2021-08-30       Impact factor: 3.210

2.  Increase in Fibrinogen Degradation Product Levels 5 Days after a Traumatic Insult.

Authors:  Hiroki Nagasawa; Kazuhiko Omori; Ikuto Takeuchi; Youichi Yanagawa
Journal:  J Emerg Trauma Shock       Date:  2020-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.